Company / Operating Income per Share
Emergent BioSolutions Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$1.92
FY2025
5-year range
-$13.92 / $6.65
FY2021-FY2025
Trend
+196.0%
vs FY2024
Sector context
#32 of 201
Health Care
What the data says
Emergent BioSolutions Inc.'s operating income per share of $1.92 is higher than 84% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-13.92 in FY2023 to $8.39 in FY2020.
Based on SEC 10-K filings.
1.92 in FY2025 with a 5-year CAGR of -25.5%. Top quartile in the Health Care sector.
Improved from $-13.92 to $1.92 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -25.5%
- 10-Year CAGR
- -
Sector benchmark
+106.7% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 196.0% year-over-year.
- Ranks #32 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.92 | +196.0% |
| FY2024 | -$2.00 | +85.6% |
| FY2023 | -$13.92 | -319.9% |
| FY2022 | -$3.31 | -149.8% |
| FY2021 | $6.65 | -20.7% |
| FY2020 | $8.39 | +280.2% |
| FY2019 | $2.21 | +3.3% |
| FY2018 | $2.14 | -30.3% |
| FY2017 | $3.06 | +14.4% |
| FY2016 | $2.68 | -28.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026